Could we reduce renal toxicity of [177Lu]Lu-PSMA radioligand therapy with furosemide?
Saved in:
| Title: | Could we reduce renal toxicity of [177Lu]Lu-PSMA radioligand therapy with furosemide? |
|---|---|
| Authors: | Pop SG; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Strobel K; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland., Heimer J; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland.; Digital Trial Intervention Plattform (dTIP), ETH Zurich, Zurich, Switzerland., Baumann C; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Omlin A; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland., Leike T; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland., Spielhofer N; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Popescu CE; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland., Zander A; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland., Burger IA; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland. Irene.burger@ksb.ch.; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Irene.burger@ksb.ch.; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. Irene.burger@ksb.ch. |
| Source: | European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Jul; Vol. 53 (9), pp. 5427-5435. Date of Electronic Publication: 2026 Apr 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41917516 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Could we reduce renal toxicity of [<superscript>177</superscript>Lu]Lu-PSMA radioligand therapy with furosemide? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pop+SG%22">Pop SG</searchLink>; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland.<br /><searchLink fieldCode="AU" term="%22Strobel+K%22">Strobel K</searchLink>; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Heimer+J%22">Heimer J</searchLink>; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland.; Digital Trial Intervention Plattform (dTIP), ETH Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Baumann+C%22">Baumann C</searchLink>; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland.<br /><searchLink fieldCode="AU" term="%22Omlin+A%22">Omlin A</searchLink>; Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Leike+T%22">Leike T</searchLink>; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Spielhofer+N%22">Spielhofer N</searchLink>; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland.<br /><searchLink fieldCode="AU" term="%22Popescu+CE%22">Popescu CE</searchLink>; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland.<br /><searchLink fieldCode="AU" term="%22Zander+A%22">Zander A</searchLink>; Department of Nuclear Medicine and Radiology, Luzerner Kantonsspital, University Teaching and Research Hospital, University of Lucerne, Lucerne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Burger+IA%22">Burger IA</searchLink>; Department of Nuclear Medicine, Kantonsspital Baden, Affiliated Hospital for Research and Teaching of the Faculty of Medicine of the University of Zurich, Baden, 5404, Switzerland. Irene.burger@ksb.ch.; Department of Nuclear Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Irene.burger@ksb.ch.; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland. Irene.burger@ksb.ch. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101140988%22">European journal of nuclear medicine and molecular imaging</searchLink> [Eur J Nucl Med Mol Imaging] 2026 Jul; Vol. 53 (9), pp. 5427-5435. <i>Date of Electronic Publication: </i>2026 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Berlin%22">Springer-Verlag Berlin </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101140988 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1619-7089 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216197070%22">16197070 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Nucl Med Mol Imaging <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41917516 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00259-026-07865-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5427 Titles: – TitleFull: Could we reduce renal toxicity of [177Lu]Lu-PSMA radioligand therapy with furosemide? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pop SG – PersonEntity: Name: NameFull: Strobel K – PersonEntity: Name: NameFull: Heimer J – PersonEntity: Name: NameFull: Baumann C – PersonEntity: Name: NameFull: Omlin A – PersonEntity: Name: NameFull: Leike T – PersonEntity: Name: NameFull: Spielhofer N – PersonEntity: Name: NameFull: Popescu CE – PersonEntity: Name: NameFull: Zander A – PersonEntity: Name: NameFull: Burger IA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1619-7089 Numbering: – Type: volume Value: 53 – Type: issue Value: 9 Titles: – TitleFull: European journal of nuclear medicine and molecular imaging Type: main |
| ResultId | 1 |